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Introduction
Squamous cell carcinoma antigen (SCCA) was fi  rst discovered 
as a marker of squamous cell carcinomas in the cervix (Kato 
and Torigoe, 1977). Cloning of the SCCA gene demonstrated 
that SCCA belongs to the serpin superfamily of serine protein-
ase inhibitors (Suminami et al., 1991). However, it soon became 
apparent that SCCA is a cross-class inhibitor and that its target 
molecules include cysteine proteinases such as cathepsin L and 
papain (Takeda et al., 1995; Schick et al., 1998). Recent work 
has revealed the presence of tandemly aligned homologous 
genes. The telomeric DNA segment contains a gene that was 
cloned by Suminami et al. (1991) and has since been designated 
SCCA1 (Schneider et al., 1995). The centromeric gene, which 
is 92% identical at the nucleic acid level, was named SCCA2. 
Interestingly, SCCA2 inhibits chymotrypsin and its relatives, as 
is expected for a serpin (Schick et al., 1997). SCCAs are also 
expressed in psoriatic epidermis (Takeda et al., 2002), which is 
where abnormal proliferation and aberrant differentiation are 
characteristic features.
The epidermis is the outermost tissue, whose primary role 
is to form a barrier against hostile environmental factors, in-
cluding UV, and it consists of four kinds of cells (i.e., cornifi  ed, 
granular, spinous, and basal cells). Although the epidermis has 
effective countermeasures against UV irradiation, its protective 
mechanisms, other than melanin, are still unknown.
We show that SCCA1 is a specifi  c endogenous inhibitor 
of c-Jun-NH2-terminal kinase-1 (JNK1) and acts to protect 
UV-exposed keratinocytes from apoptotic cell death.
Results and discussion
SCCAs are up-regulated in UV-irradiated 
and sun-exposed skin
During studies to analyze the localization of SCCAs in normal 
and diseased skin, we observed strong up-regulation of SCCAs 
in sun-exposed epidermis. In normal, sun-protected skin,  SCCAs 
were only weakly stained in the upper epidermis (Fig. 1 A). [ID]FIG1[/ID ] 
When the cheeks and eyelids of 22–84-yr-old subjects were 
  examined, all the skin tissues showed marked elevation of 
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  SCCAs, although SCCA1 was predominant. Interestingly, some 
of the nuclei in sun-exposed epidermis were heavily stained, as 
was the cytoplasm (Fig. 1 A, inset). A study involving UV irra-
diation of the buttocks of healthy volunteers confi  rmed strong 
induction of SCCA1 in the spinous to granular layers of the 
irradiated skin. An in situ hybridization study showed that SCCA1 
mRNA is weakly detectable in normal epidermis (Fig. 1 B). 
UV irradiation caused strong induction of SCCA1 mRNA in the 
top layers of the epidermis. In cultured neonatal human kerati-
nocytes (NHK), quantitative PCR analysis showed induction of 
both SCCAs, but a larger amount of SCCA1 mRNA is synthe-
sized in the later stage, after UV irradiation (Fig. 1 C). This is 
presumably the reason why the overall production of SCCA1 is 
much higher than that of SCCA2 in sun-exposed skin.
SCCAs play a key role in UV-induced 
cell death
In mouse, serpin b3a is considered the mouse orthologue of 
human SCCA because of its strong inhibition of chymotryp-
sin (Ray et al., 2005). Semiquantitative PCR analysis showed 
that mouse epidermis expressed serpin b3a (mouse SCCA), al-
though 3T3/J2, which is a mouse fi  broblast cell line, did not 
produce mouse SCCA (Fig. S1 A, available at http://www.jcb.
org/cgi/content/full/jcb.200508064/DC1). To investigate the 
photobiological role of SCCA, we stably transfected SCCA 
cDNAs into 3T3/J2; clones were established under G418 selec-
tion. Each clone expressed only one transfected gene, SCCA1 
or SCCA2 (Fig. S1 B). FACS analyses demonstrated that 
3T3/J2 cells undergo apoptosis when exposed to UV at doses 
>30 mJ/cm
2 (Fig. 2 A).  [ID]FIG2[/ID] At 30 mJ/cm
2, 37.2 ± 1.3% of the 
mock-transfected cells (control) died within 48 h (Fig. 2 B). 
When each transfected pool was used, SCCA1- or SCCA2-
transfected cells showed resistance to UV-induced apoptosis 
(P < 0.001) and only 23.8 ± 3.3% or 19.9 ± 4.4% of transfected 
cells died after UV irradiation, respectively. There was no sig-
nifi  cant difference in antiapoptotic activity between SCCA1 and 
SCCA2. We established 12 individual clones for SCCA1 and 
examined the effect of UV irradiation. Only 20.7% of the mini-
mally expressing cells survived at 50 mJ/cm
2, whereas 74.7% of 
the maximally expressing cells (2,772-fold expression) survived 
in the same condition (Fig. 2 C). Clearly, SCCA1-expressing 
clones showed a strong correlation between the expression lev-
els and the suppression of UV-induced apoptosis (r = 0.734). 
We then examined the effect of the suppression of SCCAs using 
small interfering RNA (siRNA). An H1 promoter-driven siRNA 
sequence directed against homologous sites of SCCA1 and 
SCCA2 was introduced into HaCaT cells. We used the HaCaT 
cell line because it was derived from spontaneous transforma-
tion of human adult keratinocytes (Boukamp et al., 1988) and 
synthesizes relatively high levels of both SCCAs under prolif-
erative conditions. A stably transfected cell line was established 
(small interfering SCCA [siSCCA]/HaCaT), which showed 
>90% suppression of both SCCA1 and SCCA2 mRNA levels, 
compared with the control siRNA (targeted to GFP mRNA) as 
judged by quantitative PCR (Fig. S1 C). Western blot analy-
sis showed that SCCA protein levels were also decreased to 
Figure 1.  SCCA is up-regulated by UV irradia-
tion in vivo and in vitro. (A) Immunostaining for 
SCCA1 and SCCA2 in sun-protected buttock 
skin, sun-exposed (cheek), and UV-irradiated 
buttock skin (two minimal erythema doses of 
radiation; biopsy taken after 48 h). The inset 
shows nuclear localization of SCCA1 at high 
magniﬁ  cation. Arrows indicate heavy SCCA1 
staining in the nuclei. (B) In situ mRNA hybrid-
ization of SCCA1. The sense probe did not 
show any positive reaction. The dark brown 
color seen in basal cells is caused by melanin. 
(C) Quantitative real-time PCR analysis of 
SCCA1 and SCCA2 mRNA levels in cultured 
human keratinocytes. Values given are SCCA1 
or SCCA2 mRNA levels normalized to the 
amount of G3PDH. Error bars represent the 
mean of ﬁ  ve wells ± SD. **, P < 0.01. Bars, 
100 μm.NOVEL UV PROTECTION MECHANISM IN HUMAN EPIDERMIS • KATAGIRI ET AL. 985
  approximately one-tenth of the control in siSCCA/HaCaT (Fig. 
S1 D). The siSCCA- and control siRNA-expressing cells did 
not show any changes by FACS analyses (Fig. 2 D). However, 
UV irradiation caused a signifi  cant decrease of cell survival 
in siSCCA/HaCaT cells (Fig. 2, D and E). Under conditions 
where 42.8 ± 5.0% of control cells survived, only 11.8 ± 6.3% 
of siSCCA/HaCaT cells survived (P < 0.001). Overall, the 
results suggest that SCCA1 and SCCA2 can similarly sup-
press UV-induced apoptosis and that the expression levels of 
SCCA regulate the antiapoptotic activity under UV irradiation. 
The antiapoptotic activity may be independent of proteinase-
inhibitory activity because these molecules possess highly 
Figure 2.  Overexpression or down-regulation of SCCAs signiﬁ  cantly affected UV-induced apoptosis. (A) FACS analyses of apoptotic cells using SCCA1- 
or SCCA2-transfected 3T3/J2 cells, 48 h after UV irradiation (30 mJ/cm
2). Cells were stained with FITC-conjugated Annexin V and propidium iodide. 
(B) Analyses of ﬁ  ve experiments are summarized. (C) 12 clones whose expression levels of SCCA1 mRNA distributed from 1 to 2,772-fold were estab-
lished. Using these clones, the effects of UV irradiation were examined. Cells were harvested 48 h after UV irradiation (50 mJ/cm
2) and FACS analyses 
were performed. The antiapoptotic activity correlated with SCCA1 expression. r = 0.734. (D) Using pSilencer vector, an siRNA construct targeted to a 
homologous sequence of SCCAs was stably transfected into HaCaT keratinocytes. Typical FACS analyses of nonirradiated (UV−) and UV-irradiated 
(UV+) siSCCA/HaCaT cells were shown. Apoptotic cells were analyzed 48 h after UV irradiation (75 mJ/cm
2). (E) Statistical analyses of ﬁ  ve experiments. 
Error bars represent the mean of ﬁ  ve wells ± SD.JCB • VOLUME 172 • NUMBER 7 • 2006  986
Figure 3.  SCCA1 binds with JNK1 and translocates into nucleus after UV irradiation. (A) Localization of SCCA1 before and 24 h after UV irradiation 
(50 mJ/cm
2). NHK cells were stained for SCCA1, nucleus, and F-actin with (UV+) or without UV treatment (UV−). (B) Interaction of SCCAs with p-JNK. 
HSC-4 cell extract was applied to a signal transduction antibody array, followed by incubation with HRP-conjugated antibody against either SCCA1 or 
SCCA2. Black spots indicate positive binding to p-JNK. Arrows indicate the spots representing antibodies to JNK and p-JNK. (C) HaCaT cell extracts 
transfected with control pSilencer vector or siSCCA were immunoprecipitated with anti-JNK1 antibody, followed by blotting with indicated antibodies. NOVEL UV PROTECTION MECHANISM IN HUMAN EPIDERMIS • KATAGIRI ET AL. 987
specifi  c inhibition profi  les for cysteine and serine proteinases, 
respectively. Furthermore, SCCA1 may play a primary role 
because of its abundance after the UV induction.
SCCA1 binds with phosphorylated 
JNK1 and is transferred into the nucleus 
after UV irradiation
To determine the intracellular localization of SCCAs in NHK, 
we used laser confocal microscopy. As shown in Fig. 3 A, 
SCCA1 was present exclusively in the cytoplasm of the prolif-
erating keratinocytes.  [ID]FIG3[After UV irradiation at 50 mJ/cm
2, 
SCCA1 was translocated into the nucleus and cytoplasmic 
localization was greatly reduced at 24 h. Because the SCCAs 
do not contain known nuclear translocation signals, it is likely 
that SCCAs are transported to the nucleus via binding with a 
target molecule.
To look for SCCA-binding molecules, we used a signal 
transduction antibody array. This screening resulted in the iden-
tifi  cation of JNK as a protein that binds to both SCCA1 and 
SCCA2 (Fig. 3 B). Interestingly, the binding of SCCAs was 
  observed only with active JNK (p-JNK), but not with inactive 
JNK. Anti-p38, ERK1, and ERK2 antibodies were also present 
on the membrane, but showed a negative result (unpublished 
data). Interaction between SCCA1 and JNK1 was confi  rmed 
with immunoprecipitation. Interestingly, SCCA1 was detected 
in the precipitates prepared with anti-JNK1 antibody (Fig. 3 C), 
indicating the binding of SCCA1 to JNK1 within the cell. 
SCCA1 precipitated with anti-JNK1 antibody was markedly 
  reduced in siSCCA/HaCaT.
We examined the UV responsiveness of JNK1 in cultured 
NHK cells because growing evidence suggests that JNK1 is re-
sponsible for UV-induced apoptotic cell death in other cell types 
(Butterfi  eld et al., 1997; Tong et al., 2001; Hochedlinger et al., 
2002). JNK1 was found in the cytoplasm, as well as in the nu-
cleus, of proliferating NHK cells (Fig. S2 A, available at http://
www.jcb.org/cgi/content/full/jcb.200508064/DC1). After UV 
irradiation, JNK1 accumulated into the nucleus (77.9 ± 9.4%; 
Fig. S2, A and B).
To investigate whether translocation of SCCAs is caused 
by binding with JNK1, we used a peptide inhibitor of JNKs, 
TAT-containing JNK-interacting protein-1 (JIP1) peptide 
(Bonny et al., 2001; Barr et al., 2002). First, we confi  rmed that 
in the presence of 5 μM of JIP1 peptide nuclear translocation of 
JNK1 was no longer observed, even after 50 mJ/cm
2 UV irra-
diation. JNK1 remained in the cytoplasm of most NHK cells 
(exclusively cytoplasmic, 65.4 ± 11.5%; cytoplasmic and nuclear, 
31.3 ± 8.9%) after UV irradiation (Fig. S2 B). JIP1 control 
  peptide had no effect on the localization of JNK1 (Fig. S2 C). 
We then analyzed the effect of JIP1 peptide on SCCA1 localiza-
tion. SCCA1, which was present mostly in the cytoplasm of 
control keratinocytes (92.5 ± 1.5%), promptly accumulated in 
the nucleus after UV irradiation (confi  ned nuclear, 63.6 ± 9.4%; 
peripheral nuclear, 32.0 ± 7.0%; Fig. 3, D and E). JIP1- negative 
control peptide had no effect on JNK or SCCA1 localization 
(Fig. S2 C). JIP1 peptide alone did not affect the localization of 
SCCA1. Interestingly, in the presence of 5 μM of JIP1 peptide, 
SCCA1 remained in the cytoplasm of UV-irradiated cells (81.1 ± 
8.5%; Fig. 3, D and E). The fact that JIP1 peptide inhibited 
translocation of SCCA1 into the nucleus after UV irradiation 
strongly suggests that SCCA1 requires direct or indirect associ-
ation with JNK1 for the translocation. Our results indicate that 
the interaction of SCCA1 with the complex may be involved in 
the UV-induced JNK activation.
SCCA1 speciﬁ  cally inhibits kinase activity 
of JNK1
Gene disruption studies have revealed that JNK1, but not 
JNK2, plays a key role in UV-induced apoptosis (Hochedlinger 
et al., 2002). Therefore, we investigated the effect of SCCA1 on 
JNK1 kinase activity. Because c-Jun is a well-known substrate 
of JNK, we used in vitro kinase assays to examine whether 
c-Jun phosphorylation by JNK1 is affected by SCCA1. In the 
presence of SCCA1, c-Jun phosphorylation was signifi  cantly 
reduced (Fig. 4 A).  [ID]FIG4[/IDInhibition was nearly parallel with the active 
JNK1 concentration and was observed at a uniform rate with 
increasing amounts of active JNK1 (Fig. 4 B), suggesting 
stoichiometric interaction between SCCA1 and p-JNK1. We 
also confi  rmed that SCCA1 did not show any suppression on 
the kinase activities of other MAPKs, p38α (Fig. 4 C), ERK1, 
or ERK2 (Fig. 4 D).
Interestingly, SCCA1 altered the phosphorylation of c-Jun 
in siSCCA/HaCaT keratinocytes (Fig. 4 E). Down-regulation 
of SCCA1 resulted in marked increase of phospho-c-Jun, and 
UV irradiation further enhanced the levels of c-Jun phos-
phorylation. On the other hand, down-regulation of SCCA1 
did not show any detectable changes in either the protein or 
phosphorylation levels of ERK1/2, p38α, and its primary sub-
strate, MAPK-activated protein kinase-2 (MAPKAPK2; Fig. 
4 F; Rouse et al., 1994). p38α is also known to respond to UV 
stress (Kim et al., 2005). After UV irradiation, phosphorylated 
p38α increased its intensity at 5–15 min in control HaCaT and 
  siSCCA/HaCaT cell extracts, whereas the p38α protein re-
mained at the same level. Similar changes were observed for 
MAPKAPK2. These results suggest that the kinase activity of 
JNK1 is specifi  cally regulated by SCCA1 that is also in the cell. 
It is well known that death enzyme caspases play essential roles 
in apoptotic cell death. It might be possible that suppression of 
UV-induced apoptosis by SCCA1 could include inhibition of 
certain caspases because SCCA1 is a strong inhibitor of cys-
teine proteinases. We tested this possibility and confi  rmed that 
Normal rabbit IgG was used as a nonspeciﬁ  c control (middle). Effects of UV irradiation were also examined (N, not irradiated; +UV, 5 min after 100 mJ/cm
2 
UV irradiation). (D) Effects of JIP1 peptide on SCCA1 localization. NHK cells were cultured in the presence of 5 μM of JIP1 peptide and stained for SCCA1, 
nucleus, and F-actin with (UV+, 50 mJ/cm
2) or without (UV−) UV treatment. (E) Statistical analysis of SCCA1 translocation. In each case (i.e., control [non-
treated], UV-irradiated [UV], control + JIP1 peptide [5 μM; Cont. + JIP], and UV-irradiated [50 mJ/cm
2] + JIP1 peptide [5 μM; UV + JIP]), a minimum of 
300 cells were counted three times. Error bars represent the mean of three experiments ± SD. ***, P < 0.001. Bars, 20 μm.JCB • VOLUME 172 • NUMBER 7 • 2006  988
even a 50-fold excess of SCCA1 had no effect on the activ-
ities of caspase-1–10 (Fig. S3 B, available at http://www.jcb.
org/cgi/content/full/jcb.200508064/DC1), although an equimo-
lar amount of SCCA1 strongly inhibited a typical cysteine pro-
teinase, known as papain (Fig. S3 A). Thus, in the UV-  signaling 
pathway, it is suggested that the antiapoptotic property of 
SCCA1 depends on the inhibition of JNK1.
SCCA1 transgenic mouse shows 
remarkable resistance to UV irradiation
To examine the physiological importance of SCCA up-regulation 
in the epidermis, we generated transgenic mice with a hairless 
phenotype (HR-1) that overexpress SCCA1 driven from the in-
volucrin promoter (Carroll et al., 1993). We chose involucrin 
promoter because UV irradiation induced strong up-regulation 
of SCCA1 mRNA in the upper epidermis (Fig. 1 B). Immuno-
staining of skin sections revealed strong expression of SCCA1 
in the upper epidermis of the transgenic mice, but not in the skin 
of wild-type HR-1 mice (Fig. 5 A).  [ID]FIG5[/ID]When 200 mJ/cm
2 UV was 
irradiated twice on the backs of mice, the epidermis of wild-
type HR-1 mice was seriously damaged, as seen in loss of the 
granular layer and spongiosis in the suprabasal layer (Fig. 5 B). 
Surprisingly, the same dose of UV irradiation did not cause any 
degeneration in the epidermis of SCCA1-overexpressing mice, 
although the epidermis of the transgenic mice showed hypertro-
phic and parakeratotic changes. These results clearly reveal that 
SCCA1 plays a critical role in the UV protection mechanism in 
the skin.
UV irradiation profoundly damages living organisms, 
which have had to evolve effective countermeasures. It is well 
known that UVB (290–320 nm) has the most toxic effect on 
chromosomal DNA. Basal cells, which are replicating cells, are 
physically protected with melanin, which forms a supranuclear 
melanin cap to shield the nucleus against UV irradiation. 
  Furthermore, keratinocytes as well as melanocytes produce the 
potent antiapoptotic factors bcl-2 and bcl-xL (Gillardon et al., 
1999; Taylor et al., 1999). Defi  ciency of these survival factors 
sensitizes keratinocytes to apoptotic stimuli, including UV 
irradiation. However, UV irradiation induces down-regulation 
of bcl-2 expression (Isoherranen et al., 1999). On the contrary, 
SCCA1 is up-regulated in the upper epidermis with UV irradia-
tion. Considering the importance of reproductive basal cells and 
barrier-forming cornifi  ed cells, the middle to top layers of 
spinous and granular cells are thought to represent transient 
Figure 4. SCCA1  speciﬁ  cally inhibits kinase 
activity of JNK1. (A) Inhibition of JNK1 kinase 
activity by SCCA1. An in vitro kinase pull-
down assay of the phosphorylation of c-Jun 
by JNK1 was performed using an SAPK/JNK 
assay kit. A constant amount of recombinant 
SCCA1 was incubated with various concentra-
tions of active JNK1, and changes in c-Jun 
phosphorylation were analyzed with Western 
blots. (B) Quantitative analysis of the results 
shown in A. Representative data from ﬁ  ve in-
dependent experiments are shown. Each band 
was scanned and the relative intensity was 
measured with or without SCCA1 (control) 
and plotted against the amount of p-JNK1. 
(C) Effects of SCCA1 on p38α kinase activity. 
Various concentrations of p38α MAPK were 
incubated with or without 10 times the excess 
amount of SCCA1, and changes in ATF2 phos-
phorylation were analyzed with Western blot 
using anti–phospho-ATF2 antibody. (D) Effects 
of SCCA1 on ERK1 and ERK2 kinase activity. 
Kinase activities of ERK1 or ERK2 with or 
  without 20 ng SCCA1 were measured using a 
MAPK (ERK1/2) activity assay kit. (E) Changes 
in c-Jun phosphorylation in HaCaT cells. 
  Extracts from the control or siSCCA/HaCaT 
cells were obtained 0, 5, and 15 min after UV 
irradiation (100 mJ/cm
2), and levels of c-Jun 
or phospho-c-Jun were compared with immuno-
blots. Densitmetric analysis of the ratio be-
tween c-Jun and phospho-c-Jun from three 
independent assays was also shown. Error bars 
represent the mean of ﬁ  ve experiments ± SD. 
(F) Effects of SCCA knockdown on ERK1/2, 
p38α, and MAPKAPK2 after UV irradiation. 
The same extracts used in E were immunoblot-
ted for each form of kinases.NOVEL UV PROTECTION MECHANISM IN HUMAN EPIDERMIS • KATAGIRI ET AL. 989
states that bridge the early and terminal differentiation of kera-
tinocytes. We have identifi  ed a novel UV protection mechanism 
that will function to protect the middle to top layers of epider-
mis. Observations from bullous diseases such as pemphigus 
vulgaris clearly demonstrate the importance of maintaining 
these layers. Our study suggests that under UVB exposure 
  SCCAs are highly synthesized in spinous and granular layers 
and suppress UV-induced cell death via the inhibition of JNK1. 
This is supported by our current study on the SCCA mutant 
mice, showing that up-regulation of SCCA1 in top layers of 
  epidermis was enough to block death-promoting UV stress. It 
would be benefi  cial for humans because this mechanism is not 
functioning in replicating basal cells, but is working for the dif-
ferentiated spinous and granular cells, which are destined to be 
shed after cornifi  cation.
Materials and methods
In situ hybridization
An SCCA1-speciﬁ  c sequence was PCR ampliﬁ  ed from exon 8 (642–1,001 nt) 
and cloned into pCRII vector. Complementary RNA probes were prepared 
using DIG RNA labeling mix (Roche). HRP-conjugated antidigoxigenin 
antibody (DakoCytomation) was used for visualization.
Establishment of stably transfected cell lines
SCCA1 and SCCA2 cDNAs cloned from a psoriatic cDNA library (Takeda 
et al., 2002) were subcloned into pTarget vector and transfected into 3T3/J2 
cells using Lipofectamine Plus (Invitrogen). After 4 wk of culture in 500 
μg/ml of G418, 12 colonies were isolated for SCCA1 and established as 
SCCA-expressing cell lines. Levels of SCCA expression were determined 
with Taqman PCR (Fig. S1). Expression levels among 12 colonies varied 
from 1–2,772-fold.
Vector-based siRNA
A double-stranded oligonucleotide was designed corresponding to a com-
mon sequence of human SCCAs (5′-A  A  G  C  C  A  A  C  A  C  C  A  A  G  T  T  C  A  T  G  T  -3′) 
to allow formation of the hairpin structure in the expressed oligo-RNA, 
cloned into the pSilencer vector (Ambion), and transfected into human 
  keratinocyte cell line HaCaT cells. siRNA against GFP mRNA (Ambion) 
was used as a control. Transfection was performed with Lipofectamine 
2000 (Invitrogen) and stable cell lines were established in hygromycin-B 
media for 4–6 wk.
Cell culture and UV irradiation
HaCaT, HSC-4, and 3T3/J2 cells were cultured in DME (Invitrogen) sup-
plemented with 10% FBS. NHK was cultured with EpiLife (Kurabo). Cells 
were irradiated with UVB at 60–70% conﬂ  uency using a transilluminator 
(model TOREX FL205-E-30/DMR; Toshiba Medical Supply) emitting UVB 
at 0–100 mJ/cm
2.
FACS analysis
The cells were trypsinized and stained using the Annexin V-FITC and prop-
idium iodide double-staining method (Immunotech). The cells were ana-
lyzed on a FACS Coulter EPICS XL-MCL (Beckman Coulter) with acquisition 
of a total of 10,000 events/samples to ensure adequate data.
Preparation of recombinant SCCA1
SCCA1 cDNA was subcloned into pQE-30 (QIAGEN) with a poly-histidine 
tag (6× His). His-tagged SCCA1 was expressed in Escherichia coli stain 
BL21 (DE3) cells and puriﬁ  ed on Ni
2+-nitrilotriacetate resin (QIAGEN) and 
a Mono-Q column (GE Healthcare).
Antibody array
To screen protein–protein interactions, a Signal Transduction AntibodyArray 
(Hypomatorix, Inc.) was used. The extract from a squamous cell carcinoma 
cell line, HSC-4, showed the highest expression of both SCCAs among 
NHK, HaCaT, and other SCCA cell lines. The cells were irradiated with 
50 mJ/cm
2 UVB were lysed and extracted with 1% Triton X-100 extraction 
buffer containing 15 mM Tris-HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, 
2 mM EGTA, 2 mM EDTA, 0.1 mM DTT, 80 μM bestatin, and 10 μM 
pepstatin. After incubation with the extract, the antibody array membrane 
was blotted with HRP-conjugated anti-SCCA1 or -SCCA2 mAb and detected 
with ECL Plus kit (GE Healthcare).
MAPK assays and immunoblots
Kinase activity of JNK was determined using a stress-activated protein ki-
nase (SAPK)/JNK assay kit (Cell Signaling Technology). Inhibition of JNK 
kinase activity by SCCA1 was assessed using phosphorylated-JNK1a1/
SAPK1c (Upstate Biotechnology). Phosphorylated JNK, c-Jun fusion beads, 
and SCCA1 were incubated with gentle rocking overnight at 4°C. The 
phosphorylated c-Jun was separated by SDS-PAGE and probed with anti–
phospho-c-Jun antibody (1:1,000 dilution). ERK1 and ERK2 kinase activi-
ties were measured using MAPK (ERK1/2) activity assay kit (Chemicon 
International, Inc.). Kinase activity of p38α was assessed using active 
p38α and GST-tagged ATF2 (19–96; Upstate Biotechnology) as a sub-
strate. Antibodies to ERK1/2 (Chemicon International, inc.), p-ERK1/2 
(Biosource International), p38α (Upstate Biotechnology), p-p38α, p-ATF2, 
MAPKAPK2, and phosphorylated MAPKAPK2 (Cell Signaling Technology) 
were used for immunoblots.
Involucrin-SCCA1 transgenic mice
SCCA1 cDNA was fused to the involucrin promoter (L.B. Taichman, State 
University of New York, Stony Brook, NY; Carroll et al., 1993) and trans-
genic mice were generated using BDF1 mice. To obtain the hairless 
phenotype, the involucrin-SCCA1 transgenic mice were crossed with HR-1 
mice, and SCCA1+/+ mice were obtained after three passages. UVB ir-
radiation was done with a transilluminator at 200 mJ/cm
2/day for 2 d. 
Figure 5.  Effect of UV irradiation on involucrin promoter-driven SCCA1 
transgenic mice. (A) Immunostaining of SCCAs in wild-type and transgenic 
epidermis. Parafﬁ  n-embedded skin sections were stained with antibodies 
to SCCA1 or SCCA2. (B) Histological appearance of wild-type and trans-
genic mice 24 h after UV irradiation (200 mJ/cm
2/d for 2 d). Wild-type 
(HR-1) mice demonstrated degeneration of the epidermis, including spon-
giosis (arrows) in the suprabasal layer. Involucrin-SCCA1 transgenic mice 
did not show any notable changes in UV-irradiated skin. Bars, 50 μm.JCB • VOLUME 172 • NUMBER 7 • 2006  990
Skin specimens were taken the following day and stained with hematoxylin 
and eosin or immunostained with anti-SCCA1 or -SCCA2 mAb using 
MoMap kit (Ventana Medical Systems, Inc.).
Immunohistochemical analysis and acquisition of images
Anti-SCCA1 and -SCCA2 mAbs and rabbit anti-JNK1 antibody (Santa 
Cruz Biotechnology, Inc.) were used. Alexa Fluor 555–, 488–, and 546–
conjugated secondary antibodies (Invitrogen) were used for immunoﬂ  uo-
rescence detection. Nuclei were stained with DAPI (Invitrogen). Actin 
ﬁ   laments were visualized with Alexa Fluor 488–conjugated phalloidin 
  (Invitrogen). Fluorescence images were collected using a microscope 
(model BX51WI; Olympus) equipped with a confocal system (Radiance 
2100; BioRad Laboratories) at 21°C. UPlanApo 20×/0.70  ∞/0.17, 
UPlanApo 40×/0.85  ∞/0.11–0.23, and PlanApo 60×/1.00 WLSM 
∞/0.17 were used.
Online supplemental material
Fig. S1 shows establishment of SCCA-overexpressing (A) and knockdown 
(B) cell lines. Strong suppression of the SCCA mRNA and protein in the 
knockdown cells was shown in B. Fig. S2 shows localization of JNK1 in 
cultured NHK cells before and after UV irradiation (A). Comparison of cell 
numbers in cytoplasmic or nuclear localization of JNK1 before and after 
UV irradiation was summarized in B. Effects of the JIP1 control peptide (C) 
after UV irradiation were shown. Fig. S3 shows effect of SCCA1 on   papain 
and various caspase activities. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200508064/DC1.
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